Atlas of immune-evading HIV mutations could inform design of new treatments, vaccines
Jan. 29, 2019
| By Sabrina Richards / Fred Hutch News Service
Fred Hutch scientists have constructed an atlas of mutations that HIV uses to escape broadly neutralizing antibodies, potent immune molecules that form our body’s first line of defense against the virus. The information could help guide researchers who are testing these antibodies’ potential to prevent or treat HIV infection, as well as those working to develop more effective preventive vaccines.
Fighting the stigma of HIV among communities of color takes trust — and time
Aug. 4, 2017
| By Mary Engel / Fred Hutch News Service
Vic Sorrell knows that the secret behind a successful HIV prevention study is spending the time to establish relationships and earn trust. A pioneer in community engagement, Sorrell works for the Vanderbilt HIV Vaccine Program, a unit of the Fred Hutch-based HIV Vaccine Trials Network.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.